NCT03959033 2022-08-31Patient Reported Outcome Measures (PROMs) With TrabectedinUniversity of LeedsTerminated7 enrolled
NCT03074318 2022-04-29Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by SurgeryFred Hutchinson Cancer CenterPhase 1/2 Terminated35 enrolled 21 charts
NCT01132547 2015-07-02Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerUniversity of South FloridaPhase 3 Terminated22 enrolled 9 charts
NCT00233948 2015-04-01Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable LiposarcomaCity of Hope Medical CenterPhase 1/2 Terminated29 enrolled 7 charts